To investigate the role of TRAF3IP2-AS1 in NONO-TFE3 tRCC progression, we first evaluated TRAF3IP2-AS1 expression levels in various RCC cell lines and normal cell. This evidence concerns the gene TRAF3IP2 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.